BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7008890)

  • 1. Viloxazine in the treatment of depressive neurosis: a controlled clinical study with doxepin and placebo.
    McEvoy JP; Sheridan WF; Stewart WR; Ban TA; Wilson WH; Guy W; Schaffer JD
    Br J Psychiatry; 1980 Nov; 137():440-3. PubMed ID: 7008890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
    Petrie WM; McEvoy JP; Wilson WH; Ban TA; Guy W
    Int Pharmacopsychiatry; 1980; 15(3):193-6. PubMed ID: 7016802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A collaborative study of a new antidepressant, viloxazine, in neurotic and endogenous depressives.
    Guy W; Ban TA; McEvoy JP; Petrie WM; Wilson WH; Schaffer JD
    Int Pharmacopsychiatry; 1982; 17(1):36-42. PubMed ID: 7045017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viloxazine HCl in the treatment of endogenous depression: a standard (imipramine) controlled clinical study.
    McEvoy JP; Libiger J; Wilson WH; Ban TA; Berney S; Guy W
    J Clin Psychiatry; 1982 Mar; 43(3):111-2. PubMed ID: 7037758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does viloxazine really improve sex drive? A double-blind controlled study.
    De Leo D; Magni G
    Br J Psychiatry; 1986 May; 148():597-9. PubMed ID: 3535972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind trial: vivalan against placebo in depressed elderly patients.
    Von Knorring L
    J Int Med Res; 1980; 8(1):18-21. PubMed ID: 6987113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Viloxazine in the treatment of depression in the aged. Double-blind placebo study].
    De Leo D; Ceola A; Magni G; Renesto V; Pacchioni A
    Minerva Psichiatr; 1984; 25(2):127-30. PubMed ID: 6387360
    [No Abstract]   [Full Text] [Related]  

  • 8. Multicentre study with viloxazine (Vivalan) in depressed patients.
    Kabes J; Dostal T; Náhunek K; Svestka J; Molcan J; Caplová T; Hynek K; Faltus F; Holland RP
    Int Pharmacopsychiatry; 1980; 15(4):228-39. PubMed ID: 7021448
    [No Abstract]   [Full Text] [Related]  

  • 9. Viloxazine and amitriptyline in depressive illness. A double blind controlled trial in general practice.
    Lennox IG; Asbury JF; Couldrick WG; Beswick KB
    Practitioner; 1978 Jan; 220(1315):153-6. PubMed ID: 343090
    [No Abstract]   [Full Text] [Related]  

  • 10. A placebo controlled trial of viloxazine with and without tranquillizers in depressive illness.
    Magnus RV
    J Int Med Res; 1975; 3(3):207-13. PubMed ID: 162677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viloxazine (Vivalan ICI) in depression: results of a field trial of 276 patients in neuropsychiatric practice.
    Sebjanic V; Grombein S
    Adv Biochem Psychopharmacol; 1982; 32():113-20. PubMed ID: 7046360
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinico-experimental data on the efficacy of viloxazine in depressive states].
    Pirozynski T; Chiriţă V; Mungiu OC; Luchian M; Cosmovici N
    Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):49-52. PubMed ID: 3393762
    [No Abstract]   [Full Text] [Related]  

  • 13. Alcoholism and depression: a placebo controlled study with viloxazine.
    Altamura AC; Mauri MC; Girardi T; Panetta B
    Int J Clin Pharmacol Res; 1990; 10(5):293-8. PubMed ID: 2079386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viloxazine in the treatment of endogenous depression. A standard (amitriptyline) controlled clinical study.
    Petrie WM; Ban TA; Wilson WH; Jamieson RC; Guy W
    Int Pharmacopsychiatry; 1982; 17(4):280-6. PubMed ID: 7185772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind comparison of doxepin versus bupropion in outpatients with a major depressive disorder.
    Feighner J; Hendrickson G; Miller L; Stern W
    J Clin Psychopharmacol; 1986 Feb; 6(1):27-32. PubMed ID: 3081600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Doxepin's effects on chronic pain and depression: a controlled study.
    Hameroff SR; Weiss JL; Lerman JC; Cork RC; Watts KS; Crago BR; Neuman CP; Womble JR; Davis TP
    J Clin Psychiatry; 1984 Mar; 45(3 Pt 2):47-53. PubMed ID: 6321454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Doxepin as adjunctive therapy for depressed methadone maintenance patients: a double-blind study.
    Titievsky J; Seco G; Barranco M; Kyle EM
    J Clin Psychiatry; 1982 Nov; 43(11):454-6. PubMed ID: 7174622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical and pharmacological study of the antidepressant activity of viloxazine in adult and elderly patients.
    Tosca P; Zerbi F; Romani A; Molini G; Cairoli S; Montagna M; Gabba A; Groppi A
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):270-3. PubMed ID: 4008117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age, therapeutic "milieu" and clinical outcome in depressive patients treated with viloxazine: a study with plasma levels.
    Altamura AC; Mauri MC; Guercetti G
    Prog Neuropsychopharmacol Biol Psychiatry; 1986; 10(1):67-75. PubMed ID: 3704174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacology of viloxazine hydrochloride.
    Vandel B; Vandel S; Allers G; Volmat R
    Pharmacopsychiatria; 1981 Mar; 14(2):66-70. PubMed ID: 7232498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.